VAERS Weekly Summary

2022

Jan 21, 2022

All charts and tables below reflect the data release on 01/21/2022 from the VAERS website, which includes U.S. and foreign data, and is updated through: 1/14/2022

High-Level Summary	COVID19 vaccines (Dec’2020 – present)	All other vaccines 1990-present	US Data Only COVID19 vaccines (Dec’2020 – present)	US Data Only All other vaccines 1990-present
Number of Adverse Reactions	1,053,830	868,339	732,883	755,841
Number of Life-Threatening Events	25,265	14,333	11,397	9,911
Number of Hospitalizations	118,684	82,900	49,167	38,827
Number of Deaths	22,193*	9,478*	10,162	5,254
# of Permanent Disabilities after vaccination	39,150	20,742	11,861	12,829
Number of Office Visits	164,278	49,430	143,588	47,303
# of Emergency Room/Department Visits	113,729	212,476	91,089	202,974
# of Birth Defects after vaccination	835	191	451	104

*Note that the total number of deaths associated with the COVID-19 vaccines is more than double the number of deaths associated with all other vaccines combined since the year 1990.

Deaths

[Unknowns separated from All Other Vaccines for greater clarity; in a majority of cases the Unknowns are actually Covid-19]

Adverse Events

[Unknowns separated from All Other Vaccines for greater clarity; in many cases the Unknowns are actually Covid-19]

Symptoms

The slide below was taken from an FDA document from October 22, 2020 and provides a list of possible adverse event outcomes related to the Covid-19 vaccines.

Source: ‘Vaccines and Related Biological Products Advisory Committee October 22,2020 Meeting Presentation”.

The following table lists the number of adverse events found in the VAERS data which match the outcomes listed above:

FDA Listed Symptom	Total (Non-Lethal) Adverse Events	Total Deaths
Guillain-Barre	2114	36
Acute Disseminated Encephalomyelitis	155	5
Transverse Myelitis	379	3
Encephalitis	1775	182
Convulsions/Seizures	13303	394
Stroke	12628	1157
Narcolepsy, Cataplexy	254	5
Anaphylaxis	44302	165
Acute Myocardial Infarction (Heart Attack)	3801	1134
Myocarditis/Pericarditis	16301	188
Autoimmune Disease	1261	24
Other Acute Demyelinating Diseases	290	4
Pregnancy and birth outcomes (Miscarriages)	3486	108
Other Allergic Reactions	1973	3
Thrombocytopenia	4580	337
Disseminated Intravascular Coagulation	195	61
Venous Thromboembolism	19665	1124
Arthritis and Arthralgia/Joint Pain	68496	201
Kawasaki Disease	67	1
Systemic Inflammatory Response Syndrome	646	47

Vaccination Related Risks of COVID19 Vs. Flu

These set of figures compare the COVID19 vaccine to the traditional Flu vaccines. ‘Risk of Death’ percentages depend on the ‘# of Vaccinations’ data, which is only approximate, and was pulled from the CDC’s report on Flu vaccination coverage for the 2019-2020 season, and from Our World in Data for the COVID19 vaccinations.

Covid19 vaccinations through 5/31/2021 vs. Flu vaccinations 7/1/2019 – 5/31/2020 (last complete flu season)

Vaccine Type	# of Vaccinations^[3]	# of Deaths	Risk of Death	Percentage	Deaths/Mill. Vaccinations^[3]
Flu	167,447,642^[1]	33	1 in 5,074,171	0.000020%	.20
COVID19	167,733,972^[2]	5,648	1 in 29,698	0.003367%	33.67

Risk of dying from COVID vaccine is 171 times greater than Flu Vaccine

Vaccine Type	# of Vaccinations^[3]	# of Adverse Reactions	Risk of Adverse Reaction	Percentage	AEs/Mill. Vaccinations^[3]
Flu	167,447,642	9,716	1 in 17,234	0.005802%	58.02
COVID19	167,733,972	544,211	1 in 308	0.3244%	3,244

Risk of adverse reaction from COVID vaccine is 56 times greater than Flu Vaccine

^[1]number of flu vaccinations based on estimated flu vaccine coverage data from CDC and estimated population data from US Census. Yearly flu vaccination data covers a period of time from 7/1 to 5/31 of the following year.
^[2]number of covid19 vaccinations based on estimates from Our World in Data ^[2]number of covid19 vaccinations based on estimates from Our World in Data
^[3]Persons vaccinated with at least one dose.

Vaccine Data by Manufacturer

Manufacturer	# of Deaths	% Deaths	Average Deaths/Day	# US Deaths	US Doses Administered	Average US Deaths/Mill. Doses	Days since EUA approval	EUA Approval Date-
Janssen (JNJ)	1978	8.9%	6.14	1286	18,065,529	71.19	322	2/26/2021
Moderna	5438	24.48%	13.87	4207	202,127,731	20.81	392	12/18/2020
Pfizer/Biontech	14708	66.2%	36.86	4641	311,207,242	14.91	399	12/11/2020
Unknown	93	0.42%		41	464,369

Manufacturer	# of AEs	% AEs	Average AEs/Day	# US AEs	US Doses Administered	Average US AEs/Mill. Doses	Days since EUA approval	EUA Approval Date
Janssen (JNJ)	77028	7.3%	239.22	65125	18,065,529	3604.93	322	2/26/2021
Moderna	383140	36.29%	977.4	336228	202,127,731	1663.44	392	12/18/2020
Pfizer/Biontech	593066	56.17%	1486.38	331247	311,207,242	1064.39	399	12/11/2020
Unknown	2642	0.25%		1644	464,369